450.2000 1.85 (0.41%)
NSE Mar 20, 2026 15:31 PM
Volume: 67,246
 

Axis Direct
We expect gross margins to be impacted due to an increase in revenue share from the non-regulated market going onwards, therefore recommend HOLD' with a target price of Rs 1,670/share (PE 20x for FY23EPS).
Promoters unpledged 9.28% of shares in last quarter. Total pledge stands at 26.04% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended